HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Niederer, Heather A ^a   Laydon, Daniel J ^a   Melamed, Anat ^a   Elemans, Marjet ^a   Asquith, Becca ^a   Matsuoka, Masao ^b   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

CD8+ T cell; HAM TSP; HBZ; HTLV 1; HTLV 1 basic leucine zipper factor; HTLV 1 associated myelopathy tropical spastic paraparesis; Human T cell lymphotropic virus type 1; Integration site

Indexed keywords

PROTEIN HBZ; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; EPITOPE; HBZ PROTEIN, HUMAN T-CELL LEUKEMIA VIRUS TYPE I; PROTEIN BINDING; VIRAL PROTEIN;

ALLELE; ARTICLE; BINDING AFFINITY; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JAPAN; JAPANESE (PEOPLE); LYMPHOCYTE CLONE; MAJOR CLINICAL STUDY; PROTEIN BINDING; PROVIRUS; T LYMPHOCYTE; TROPICAL SPASTIC PARAPARESIS; VIRUS DNA CELL DNA INTERACTION; GENE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HUMAN T-LYMPHOTROPIC VIRUS 1; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS LOAD;

HUMAN T-LYMPHOTROPIC VIRUS 1;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARRIER STATE; EPITOPES; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PARAPARESIS, TROPICAL SPASTIC; PROTEIN BINDING; VIRAL LOAD; VIRAL PROTEINS;

EID: 84907994504     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-172     Document Type: Article

References (36)

1. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Gessain A, Cassar O, Front Microbiol 2012 3 388 23162541
2. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CRM, Blood 2012 120 3488 3490 10.1182/blood-2012-07-445593 22955925
3. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL, Blood 2008 112 3788 3797 10.1182/blood-2008-04-154286 18689544
4. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Satou Y, Yasunaga J-i, Yoshida M, Matsuoka M, Proc Natl Acad Sci 2006 103 720 725 10.1073/pnas.0507631103 16407133
5. Mechanisms of HTLV-1 persistence and transformation. Boxus M, Willems L, Br J Cancer 2009 101 1497 1501 10.1038/sj.bjc.6605345 19861996
6. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Yamano Y, Sato T, Front Microbiol 2012 3 389 23162542
7. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, J Neurovirol 1998 4 586 593 10.3109/13550289809114225 10065900
8. CTL quality and the control of human retroviral infections. Bangham CRM, Eur J Immunol 2009 39 1700 1712 10.1002/eji.200939451 19582737
9. HTLV-1 and innate immunity. Journo C, Mahieux R, Viruses 2011 3 1374 1394 10.3390/v3081374 21994785
10. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR, Proc Natl Acad Sci U S A 1999 96 3848 3853 10.1073/pnas.96.7.3848 10097126
11. Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. Goon PKC, Biancardi A, Fast N, Igakura T, Hanon E, Mosley AJ, Asquith B, Gould KG, Marshall S, Taylor GP, Bangham CRM, J Infect Diseases 2004 189 2294 2298 10.1086/420832
12. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M, Int Immunol 1991 3 761 767 10.1093/intimm/3.8.761 1911545
13. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S, Bangham CR, J Virol 1995 69 2649 2653 7533860
14. 5′-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo. Koiwa T, Hamano-usami A, Ishida T, Okayama A, Yamaguchi K, Kamihira S, Koiwa T, Hamano-usami A, Ishida T, Okayama A, Yamaguchi K, Kamihira S, Watanabe T, J Virol 2002 76 9389 9397 10.1128/JVI.76.18.9389-9397.2002 12186921
15. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K, Takatsuki K, Blood 1996 88 3065 3073 8874205
16. The role of HTLV-1 clonality, proviral structure and genomic integration site in adult T cell leukemia/lymphoma. Cook LB, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L, Taylor GP, Matsuoka M, Bangham CRM, Blood 2014 doi:10.1182/blood-2014-02-553602
17. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Furukawa Y, Kubota R, Tara M, Izumo S, Osame M, Blood 2001 97 987 993 10.1182/blood.V97.4.987 11159527
18. A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. Asquith B, Mosley AJ, Barfield A, Marshall SEF, Heaps A, Goon P, Hanon E, Tanaka Y, Taylor GP, Bangham CRM, The Journal of General Virology 2005 86 1515 1523 10.1099/vir.0.80766-0 15831965
19. Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. Sabouri AH, Usuku K, Hayashi D, Izumo S, Ohara Y, Osame M, Saito M, Blood 2008 112 2411 2420 10.1182/blood-2008-02-140335 18502825
20. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Saito M, Matsuzaki T, Satou Y, Yasunaga J-I, Saito K, Arimura K, Matsuoka M, Ohara Y, Retrovirology 2009 6 19 10.1186/1742-4690-6-19 19228429
21. HLA class I binding of HBZ determines outcome in HTLV-1 infection. Macnamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K, Yasukawa M, Taylor G, Bangham CRM, Asquith B, PLoS Pathog 2010 6 1001117 10.1371/journal.ppat.1001117 20886101
22. The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains. Van Dooren S, Pybus OG, Salemi M, Liu H-F, Goubau P, Remondegui C, Talarmin A, Gotuzzo E, Alcantara LCJ, Galvão-Castro B, Vandamme A-M, Mol Biol Evol 2004 21 603 611 14739252
23. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CRM, PLoS Pathog 2013 9 1003271 10.1371/journal.ppat.1003271 23555266
24. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T cell clones. Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, Berry C, Bushman FD, Taylor GP, Bangham CRM, Blood 2011 117 3113 3122 10.1182/blood-2010-10-312926 21228324
25. Quantification of HTLV-1 clonality and TCR diversity. Laydon DJ, Melamed A, Sim A, Gillet NA, Sim K, Darko S, Kroll JS, Douek DC, Price DA, Bangham CRM, Asquith B, PLoS Comput Biol 2014 10 1003646 10.1371/journal.pcbi.1003646 24945836
26. HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. Meekings KN, Leipzig J, Bushman FD, Taylor GP, Bangham CRM, PLoS Pathog 2008 4 1000027 10.1371/journal.ppat.1000027 18369476
27. Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. Gillet NA, Gutiérrez G, Rodriguez SM, de Brogniez A, Renotte N, Alvarez I, Trono K, Willems L, PLoS Pathog 2013 9 1003687 10.1371/journal.ppat.1003687 24098130
28. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, Alvarez C, Gotuzzo E, Clark D, Farre L, Bittencourt A, Asquith B, Taylor GP, Bangham CRM, PLoS Pathog 2013 9 1003263 10.1371/journal.ppat.1003263 23592987
29. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Tendler CL, Greenberg SJ, Blattner W, Manns A, Murphy E, Fleisher T, Hanchard B, Morgan O, Burton JD, Nelson DL, Proc Natl Acad Sci U S A 1990 87 5218 5222 10.1073/pnas.87.13.5218 2367534
30. How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis? Azimi N, Mariner J, Jacobson S, Waldmann TA, AIDS Res Hum Retroviruses 2000 16 1717 1722 10.1089/08892220050193209 11080816
31. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. Kaplan JEOM, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS, J Acquir Immune Defic Syndr 1990 3 1096 1101 2213510
32. HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests. Tosswill JHC, Taylor GP, Tedder RS, Mortimer PP, Voss LD, Mulligan J, Br Med J 2000 320 611 612 10.1136/bmj.320.7235.611
33. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M, Inoko H, Immunogenetics 2005 57 717 729 10.1007/s00251-005-0048-3 16215732
34. HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. Suemori K, Fujiwara H, Ochi T, Ogawa T, Matsuoka M, Matsumoto T, Mesnard J-M, Yasukawa M, J Gen Virol 2009 90 1806 1811 10.1099/vir.0.010199-0 19423550
35. In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. Hilburn S, Rowan A, Demontis M-A, MacNamara A, Asquith B, Bangham CRM, Taylor GP, J Infect Dis 2011 203 529 536 10.1093/infdis/jiq078 21208912
36. The UCSC Table Browser data retrieval tool. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ, Nucleic Acids Res 2004 32 493 D496 10.1093/nar/gkh103 14681465